glutathione belo medical group Belo Medical Group | Which
Description
(2016) MicroRNA-214 acts as oncogene in breast cancer by targeting the PTENPI3K/Akt signaling pathway, Int
BMP-2 but not VEGF or PDGF in fibrin matrix supports bone healing in a delayed-union rat model
Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men short version
What happened
A total of 53 patients were randomized in a 1:1 ratio to receive BPC 157 enema, 80 mg once daily for 2 weeks, or placebo
